Squarepoint’s NxStage Medical Inc. NXTM Stock Holding History

Squarepoint’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,600	Closed	-$351K	–	2423
2018 Q3	$351K	Buy	+12,600	New	+$354K	﹤0.01%	1465
2018 Q1	–	Sell	-11,500	Closed	-$279K	–	2416
2017 Q4	$279K	Sell	11,500 -76,500	-87%	-$2.02M	﹤0.01%	1562
2017 Q3	$2.43M	Buy	+88,000	New	+$2.35M	0.05%	451
2016 Q4	–	Sell	-9,194	Closed	-$230K	–	2006
2016 Q3	$230K	Buy	+9,194	New	+$214K	0.02%	846
2015 Q1	–	Sell	-10,192	Closed	-$183K	–	514
2014 Q4	$183K	Buy	+10,192	New	+$164K	0.18%	177

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's NXTM Position: Q4 2018 in Review

Squarepoint sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 12,600 shares — an estimated $351K sold.

Squarepoint first reported a position in NXTM in Q4 2014 and held it in 5 quarters. The position peaked at $2.43M in Q3 2017. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

Squarepoint reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
Squarepoint sold 12,600 NxStage Medical Inc. shares in Q4 2018, an estimated $351K.
Squarepoint first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 5 quarters.
Squarepoint's NxStage Medical Inc. position peaked at $2.43M in Q3 2017.
172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Squarepoint's 13F filing for Q4 2018, filed 14 Feb 2019.